Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edema

Journal of Hepatology

Volumn 57, Issue 6, 2012, Pages 1199-1206

  Solà, Elsa ^a,b,c,d   Watson, Hugh ^e   Graupera, Isabel ^a,b,c,d   Turón, Fanny ^a,b,c,d   Barreto, Rogelio ^a,b,c,d   Rodríguez, Ezequiel ^a,b,c,d   Pavesi, Marco ^a,b,c   Arroyo, Vicente ^a,b,c,d   Guevara, Mónica ^a,b,c,d   Ginès, Pere ^a,b,c,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Instituto Reina Sofia de Investigacion Nefrologica   (Spain)

^e SANOFI   (France)

Author keywords

Ascites; Cirrhosis; Edema; Hyponatremia; Quality of life

Indexed keywords

SODIUM;

ADULT; AGED; ARTICLE; ASCITES; DISEASE SEVERITY; FEMALE; HUMAN; HYPONATREMIA; LEG EDEMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SODIUM BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ASCITES; EDEMA; FEMALE; HUMANS; LEG; LIVER CIRRHOSIS; MALE; MIDDLE AGED; QUALITY OF LIFE; SODIUM;

EID: 84869231273     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.07.020     Document Type: Article

References (48)

1. P. Ginès, T. Berl, and M. Bernardi Hyponatremia in cirrhosis: from pathogenesis to treatment Hepatology 28 1998 851
2. P. Angeli, F. Wong, and H. Watson CAPPS Investigators. Hyponatremia in cirrhosis: results of a patient population survey Hepatology 44 2006 1535 1542
3. P. Ginès, and M. Guevara Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management Hepatology 48 2008 1002 1010
4. J. Córdoba, R. García-Martinez, and M. Simón-Talero Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence Metab Brain Dis 25 2010 73 80
5. D. Häussinger, G. Kircheis, R. Fischer, F. Schliess, and S. Vom Dahl Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 32 2000 1035 1038
6. T. Restuccia, B. Gómez-Ansón, M. Guevara, C. Alessandria, A. Torre, and M.E. Alayrach Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis Hepatology 39 2004 1613 1622
7. D. Häussinger, J. Laubenberger, S. Vom Dahl, T. Ernst, S. Bayer, and M. Langer Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy Gastroenterology 107 1994 1475 1480
8. J. Córdoba, J. Alonso, A. Rovira, C. Jacas, F. Sanpedro, and L. Castells The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation J Hepatol 35 2001 598 604
9. J. Córdoba, J. Gottstein, and A.T. Blei Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis J Hepatol 29 1998 589 594
10. D. Haussinger Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis Hepatology 43 2006 1187 1190
11. D.L. Shawcross, S. Balata, S.W. Olde Damink, P.C. Hayes, J. Wardlaw, and I. Marshall Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia Am J Physiol Gastrointest Liver Physiol 287 2004 G503 G509
12. P. Amodio, F. Del Piccolo, E. Petteno, D. Mapelli, P. Angeli, and R. Iemmolo Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients J Hepatol 35 2001 37 45
13. R. Jalan, R.A. Elton, D.N. Redhead, K.J. Simpson, N.D.C. Finlayson, and P.C. Hayes Analysis of prognostic variables in the prediction of shunt failure, variceal rebleeding, early mortality and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt (TIPSS) J Hepatol 23 1995 123 128
14. M. Guevara, M.E. Baccaro, J. Ríos, M. Martín-Llahí, J. Uriz, and L. Ruiz del Arbol Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration Liver Int 30 2010 1137 1142
15. M. Guevara, M.E. Baccaro, A. Torre, B. Gómez-Ansón, J. Ríos, and F. Torres Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis Am J Gastroenterol 104 2009 1382 1389
16. O. Riggio, S. Angeloni, F.M. Salvatori, A. De Santis, F. Cerini, and A. Farcomeni Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts Am J Gastrol 103 2008 2738 2746
17. M.C. Londoño, M. Guevara, A. Rimola, M. Navasa, P. Taurà, and A. Mas Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation Gastroenterology 130 2006 1135 1143
18. M.F. Dawwas, J.D. Lewsey, J.M. Neuberger, and A.E. Gimson The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study Liver Transpl 13 2007 1115 1124
19. S.W. Biggins, H.J. Rodriguez, P. Bacchetti, N.M. Bass, J.P. Roberts, and N.A. Terrault Serum sodium predicts mortality in patients listed for liver transplantation Hepatology 41 2005 32 39
20. W.R. Kim, S.W. Biggins, W.K. Kremers, R.H. Wiesner, P.S. Kamath, and J.T. Benson Hyponatremia and mortality among patients on the liver-transplant waiting list N Engl J Med 359 2008 1018 1026
21. G. Marchesini, G. Bianchi, P. Amodio, F. Salerno, M. Merli, and C. Panella Factors associated with poor health-related quality of life of patients with cirrhosis Gastroenterology 120 2001 170 178
22. I. Les, E. Doval, M. Flavià, C. Jacas, G. Cárdenas, and R. Esteban Quality of life in cirrhosis is related to potentially treatable factors Eur J Gastroenterol Hepatol 22 2010 221 227
23. S. Saab, A.B. Ibrahim, A. Shpaner, Z.M. Younossi, C. Lee, and F. Durazo MELD fails to measure quality of life in liver transplant candidates Liver Transpl 11 2005 218 233
24. Z.M. Younossi, N. Boparai, L.L. Price, M.L. Kiwi, M. McCormick, and G. Guyatt Health-related quality of life in chronic liver disease: the impact of the type and severity of disease Am J Gastroenterol 96 2001 2199 2205
25. A. Afendy, J.B. Kallman, M. Stepanova, Z. Younpszai, R.D. Aquino, and G. Bianchi Predictors of health-related quality of life in patients with chronic liver disease Aliment Pharmacol Ther 30 2009 469 476
26. P. Ginès, F. Wong, H. Watson, S. Milutinovic, and L.R. del Arbol HypoCAT Study Investigators. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial Hepatology 48 2008 204 213
27. P. Ginès, F. Wong, H. Watson, R. Terg, R. Bruha, and J.P. Zarski NormoCAT Study Investigators. Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia-a randomized, double-blind, placebo-controlled study Aliment Pharmacol Ther 31 2010 834 845
28. F. Wong, P. Gines, H. Watson, Y. Horsmans, P. Angeli, and P. Gow Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis J Hepatol 53 2010 283 290
29. F. Wong, H. Watson, A. Gerbes, H. Vilstrup, S. Badalamenti, and M. Bernardi Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity Gut 61 2012 108 116
30. J. Ware, and C. Sherbourne 36-item short form health survey (SF-36). I. Conceptual framework and item selection Med Care 30 1992 473 482
31. J.E. Warw, K.K. Snow, M. Kosinski, and B. Gandek The SF-36 health survey. Manual and interpretation guide 1993 The Health Institute, New England Medical Center Boston, MA
32. J.E. Warw, M. Kosinski, and J.E. Dewey How to score version 2 of the SF-36 health survey 2000 Quality Incorporated Lincoln, RI
33. P. Gines, P. Angeli, K. Lenz, S. Moller, K. Moore, and R. Moreu European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis J Hepatol 53 2010 397 417
34. L.A. Allen, M. Gheorghiade, K.J. Reid, S.M. Dunlay, P.S. Chan, and P.J. Hauptman Identifying patients hospitalized with heart failure at risk for unfavourable future quality of life Circ Cardiovasc Qual Outcomes 4 2011 389 398
35. H.J. Adrogué, and N.E. Madias Hyponatremia N Engl J Med 342 2000 1581 1589
36. R.H. Sterns, and S.M. Silver Brain volume regulation in response to hypo-osmolality and its correction Am J Med 119 Suppl. 1 2006 S12 S16
37. J.S. Videen, T. Michaelis, P. Pinto, and B.D. Ross Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study J Clin Invest 95 1995 788 793
38. J. Barsony, M.B. Manigrasso, Q. Xu, H. Tam, and J.G. Verbalis Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats Age 2012 Jan 5 [Epub ahead of print]
39. T. Miyazaki, K. Ohmoto, T. Hirose, and H. Fujiki Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptan J Endocrinol 206 2010 105 111
40. B. Renneboog, W. Musch, X. Vandemergel, M.U. Manto, and G. Decaux Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits Am J Med 119 2006 71.e1-8
41. G. Soriano, E. Román, J. Córdoba, M. Torrens, M. Poca, and X. Torras Cognitive dysfunction in cirrhosis is associated with falls. A prospective study Hepatology 55 2012 1922 1930
42. E. Román, J. Córdoba, M. Torrens, X. Torras, C. Villanueva, and V. Vargas Minimal hepatic encephalopathy is associated with falls Am J Gastroenterol 106 2011 476 482
43. G. Teuber, A. Schafer, J. Rimpel, K. Paul, C. Keicher, and M. Scheurlen Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: association with demographic factors, inflammatory activity and degree of fibrosis J Hepatol 49 2008 923 929
44. A. John-Baptiste, G. Tomlinson, P.C. Hsu, M. Krajden, E.J. Heathcote, and A. Laporte Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C Am J Gastroenterol 104 2009 2439 2448
45. A. Arguedas, T.G. DeLawrence, and B.M. McGUIRE Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis Dig Dis Sci 48 2003 1622 1626
46. S.S. Sidhu, O. Goyal, B.P. Mishra, A. Sood, R.S. Chhina, and R.K. Soni Rifaximin improves psychometric and health-related quality of life in patients with cirrhosis with minimal hepatic encephalopathy (the RIME Trial) Am J Gastroenterol 106 2011 307 316
47. E. Kalaitzakis, M. Simrén, R. Olsson, P. Henfridsson, I. Hugosson, and M. Bengtsson Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life Scand J Gastroenterol 41 2006 1464 1472
48. J.S. Bajaj, A. Sanyal, D. Bell, H. Gilles, and M. Heuman Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients Aliment Pharmacol Ther 31 2010 1012 1017